TH153719A - Inhibitors of Glucosyl Ceramides Syntase - Google Patents
Inhibitors of Glucosyl Ceramides SyntaseInfo
- Publication number
- TH153719A TH153719A TH1301005224A TH1301005224A TH153719A TH 153719 A TH153719 A TH 153719A TH 1301005224 A TH1301005224 A TH 1301005224A TH 1301005224 A TH1301005224 A TH 1301005224A TH 153719 A TH153719 A TH 153719A
- Authority
- TH
- Thailand
- Prior art keywords
- treatment
- inhibitors
- diseases
- ceramides
- metabolic
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title claims abstract 5
- 230000002401 inhibitory effect Effects 0.000 title claims abstract 5
- 150000002305 glucosylceramides Chemical class 0.000 title claims abstract 4
- 208000008466 Metabolic Disease Diseases 0.000 claims abstract 4
- 201000010099 disease Diseases 0.000 claims abstract 4
- 201000011510 cancer Diseases 0.000 claims abstract 3
- 241000045500 Diseae Species 0.000 claims abstract 2
- 102000004190 Enzymes Human genes 0.000 claims abstract 2
- 108090000790 Enzymes Proteins 0.000 claims abstract 2
- 206010024579 Lysosomal storage disease Diseases 0.000 claims abstract 2
- 238000002641 enzyme replacement therapy Methods 0.000 claims abstract 2
- 230000002132 lysosomal Effects 0.000 claims abstract 2
- 230000002503 metabolic Effects 0.000 claims abstract 2
- 238000002560 therapeutic procedure Methods 0.000 claims abstract 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000002194 synthesizing Effects 0.000 claims 1
- 229940106189 Ceramides Drugs 0.000 abstract 1
- 239000003560 cancer drug Substances 0.000 abstract 1
- 150000001783 ceramides Chemical class 0.000 abstract 1
Abstract
DC60 (03/12/56) การประดิษฐ์นี้ัเกี่ยวกับ สารยับยั้งของ กลูโคซิลเซรามีด ซินเทส (GCS) ที่ใช้ประโยชน์ สำหรับการรักษา โรคจากการบกพร่องของเมตาโบลิซึม (metabolic diseases), เช่น โรค lysosomal storage diseases, โดยลำพัง หรือ ร่วมกับ การบำบัดรักษาโดยการให้เอนไซม์ทดเเทน (enzyme replacement therapy), และสำหรับการรักษา โรคมะเร็ง (cancer). การประดิษฐ์นี้ัเกี่ยวกับ สารยับยั้งของ กลูโคซิลเซรามีด ซินเทส(GCS)ที่ใช้ประโยชน์ สำหรับการรักษา โรคจากการบกพร่องของเมตาโบลิซิม(metabolic diseases)เช่น โรค lysosomal storage diseaes โดยลำพัง หรือ ร่วมกับ การบำบัดรักษาโรคการให้เองไซม์ทดเเทน (enzyme replacement thrapy)เเละสำหรับการรักษา โรคมะเร็ง(cancer) สิทธิบัตรยา DC60 (03/12/56) This invention is about Inhibitors of Useful Glucosyl Ceramides (GCS) For treatment Diseases caused by metabolic diseases, such as lysosomal storage diseases, alone or in combination with enzyme replacement therapy, and for the treatment of cancer. This invention is about Inhibitors of Glucosil Ceramides Utilized Syntase (GCS) For treatment Disease caused by metabolic deficiencies (metabolic diseases) such as lysosomal storage diseaes alone or in conjunction with therapy, enzyme replacement thrapy and for treatment. Cancer drug patent
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH153719A true TH153719A (en) | 2016-06-30 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202091568A1 (en) | GLUCOSYL CERAMIDE SYNTHASE INHIBITORS | |
| UA118248C2 (en) | Glucosylceramide synthase inhibitors | |
| CR20140108A (en) | CYCLOPROPANOAMINE COMPOUND | |
| BR112014029301A2 (en) | Methods of treating metabolic syndrome by modulating heat shock protein (hsp) 90-beta | |
| WO2013033657A3 (en) | CaMKII, IP3R, CALCINEURIN, P38 AND MK2/3 INHIBITORS TO TREAT METABOLIC DISTURBANCES OF OBESITY | |
| BR112015006524A2 (en) | quinazolinone derivatives as parp inhibitors | |
| SG10201804952QA (en) | Glucosylceramide synthase inhibitors | |
| PH12015502021A1 (en) | Salt forms of (s)-quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate | |
| BR112015020667A2 (en) | method of preparing glucosylceramide synthase inhibitors | |
| BR112016001928A2 (en) | piperidine derivatives urea | |
| WO2011103028A3 (en) | Compositions and methods for inhibiting mmset | |
| TH153719A (en) | Inhibitors of Glucosyl Ceramides Syntase | |
| TN2013000368A1 (en) | Glucosylceramide synthase inhibitors | |
| TH154733A (en) | Tetrahydro-pyrido-pyrimidine derivatives (tetrahydro-pyrido-pyrimidine) | |
| TH153182A (en) | Beta-sequestrate inhibitors | |
| TH156196A (en) | Antiviral Compounds | |
| TH152461A (en) | 3-pyrimidin-4-il-oxasolidin-2-transfer as a inhibitor of mutated IDH. | |
| TH138553A (en) | Concomitant use of HSP90 inhibitors | |
| TH170238A (en) | Salt form of (S) - quinuclidin-3-il (2- (2- (4-fluorophenyl) thiazole-4-il) propane-2-il) carbamate | |
| TH131403A (en) | New pyrimidine compounds As mTOR and PI3K inhibitors | |
| TH117889S (en) | Wardrobe | |
| TH154783A (en) | An agonist of tyrosine phosphatase-1 protein with SRC, homology-2, and a treatment using the same. | |
| EA202090141A1 (en) | TREATMENT OF GENOTYPIATED PATIENTS WITH DIABETES DPP-4 INHIBITORS SUCH AS LINAGLIPTIN | |
| TH153174A (en) | Immidazopyridinone Compound | |
| TH159388A (en) | Macroxylic compounds and their production methods |